5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          To develop a reporting guideline for overviews of reviews of healthcare interventions.

          Design

          Development of the preferred reporting items for overviews of reviews (PRIOR) statement.

          Participants

          Core team (seven individuals) led day-to-day operations, and an expert advisory group (three individuals) provided methodological advice. A panel of 100 experts (authors, editors, readers including members of the public or patients) was invited to participate in a modified Delphi exercise. 11 expert panellists (chosen on the basis of expertise, and representing relevant stakeholder groups) were invited to take part in a virtual face-to-face meeting to reach agreement (≥70%) on final checklist items. 21 authors of recently published overviews were invited to pilot test the checklist.

          Setting

          International consensus.

          Intervention

          Four stage process established by the EQUATOR Network for developing reporting guidelines in health research: project launch (establish a core team and expert advisory group, register intent), evidence reviews (systematic review of published overviews to describe reporting quality, scoping review of methodological guidance and author reported challenges related to undertaking overviews of reviews), modified Delphi exercise (two online Delphi surveys to reach agreement (≥70%) on relevant reporting items followed by a virtual face-to-face meeting), and development of the reporting guideline.

          Results

          From the evidence reviews, we drafted an initial list of 47 potentially relevant reporting items. An international group of 52 experts participated in the first Delphi survey (52% participation rate); agreement was reached for inclusion of 43 (91%) items. 44 experts (85% retention rate) completed the second Delphi survey, which included the four items lacking agreement from the first survey and five new items based on respondent comments. During the second round, agreement was not reached for the inclusion or exclusion of the nine remaining items. 19 individuals (6 core team and 3 expert advisory group members, and 10 expert panellists) attended the virtual face-to-face meeting. Among the nine items discussed, high agreement was reached for the inclusion of three and exclusion of six. Six authors participated in pilot testing, resulting in minor wording changes. The final checklist includes 27 main items (with 19 sub-items) across all stages of an overview of reviews.

          Conclusions

          PRIOR fills an important gap in reporting guidance for overviews of reviews of healthcare interventions. The checklist, along with rationale and example for each item, provides guidance for authors that will facilitate complete and transparent reporting. This will allow readers to assess the methods used in overviews of reviews of healthcare interventions and understand the trustworthiness and applicability of their findings.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: not found
          • Article: not found

          RoB 2: a revised tool for assessing risk of bias in randomised trials

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

            The number of published systematic reviews of studies of healthcare interventions has increased rapidly and these are used extensively for clinical and policy decisions. Systematic reviews are subject to a range of biases and increasingly include non-randomised studies of interventions. It is important that users can distinguish high quality reviews. Many instruments have been designed to evaluate different aspects of reviews, but there are few comprehensive critical appraisal instruments. AMSTAR was developed to evaluate systematic reviews of randomised trials. In this paper, we report on the updating of AMSTAR and its adaptation to enable more detailed assessment of systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. With moves to base more decisions on real world observational evidence we believe that AMSTAR 2 will assist decision makers in the identification of high quality systematic reviews, including those based on non-randomised studies of healthcare interventions.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A typology of reviews: an analysis of 14 review types and associated methodologies.

              The expansion of evidence-based practice across sectors has lead to an increasing variety of review types. However, the diversity of terminology used means that the full potential of these review types may be lost amongst a confusion of indistinct and misapplied terms. The objective of this study is to provide descriptive insight into the most common types of reviews, with illustrative examples from health and health information domains. Following scoping searches, an examination was made of the vocabulary associated with the literature of review and synthesis (literary warrant). A simple analytical framework -- Search, AppraisaL, Synthesis and Analysis (SALSA) -- was used to examine the main review types. Fourteen review types and associated methodologies were analysed against the SALSA framework, illustrating the inputs and processes of each review type. A description of the key characteristics is given, together with perceived strengths and weaknesses. A limited number of review types are currently utilized within the health information domain. Few review types possess prescribed and explicit methodologies and many fall short of being mutually exclusive. Notwithstanding such limitations, this typology provides a valuable reference point for those commissioning, conducting, supporting or interpreting reviews, both within health information and the wider health care domain.
                Bookmark

                Author and article information

                Contributors
                Role: research associate
                Role: research associate
                Role: head of department
                Role: assistant professor
                Role: associate professor
                Role: professor
                Role: senior research fellow
                Role: associate professor
                Role: principal research lead
                Role: postdoctoral research fellow
                Role: head of department
                Role: associate professor
                Role: professor
                Role: professor
                Role: professor of public health and digital medicine
                Role: meta-researcher
                Role: professor
                Role: professor
                Role: senior research associate
                Role: professor
                Journal
                BMJ
                BMJ
                BMJ-UK
                bmj
                The BMJ
                BMJ Publishing Group Ltd.
                0959-8138
                1756-1833
                2022
                09 August 2022
                : 378
                : e070849
                Affiliations
                [1 ]Alberta Research Centre for Health Evidence, Department of Pediatrics, University of Alberta, Edmonton, AB, Canada
                [2 ]Institute for Research in Operative Medicine, Witten/Herdecke University, Witten, Germany
                [3 ]Clinical Pharmacology Unit, Faculty of Medicine and Institute of Molecular Medicine, University of Lisbon, Lisbon, Portugal
                [4 ]Li Ka Shing Knowledge Institute, St Michael’s Hospital, Toronto, ON, Canada
                [5 ]Epidemiology Division and Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
                [6 ]Queen’s Collaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, ON, Canada
                [7 ]Clinical Epidemiology Program, Ottawa Hospital Research Institute, and School of Epidemiology and Public Health, University of Ottawa, ON, Canada
                [8 ]School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
                [9 ]Department of Ophthalmology, School of Medicine, University of Colorado Anschutz Medical Campus, Denver, CO, USA
                [10 ]Institute of Health Economics, Edmonton, AB, Canada
                [11 ]Department of Health Technology Assessment and Evidence Based Healthcare, Ministry of Health, Chile
                [12 ]School of Medicine, Autonomous University of Chile, Santiago, Chile
                [13 ]Faculty of Nursing, University of Alberta, Edmonton, Canada
                [14 ]Johns Hopkins University School of Medicine, Baltimore, MD, USA
                [15 ]Faculty of Electrical Engineering and Computer Science, University of Applied Science Stralsund, Stralsund, Germany
                [16 ]Department of Hygiene, Social-Preventive Medicine, and Medical Statistics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece
                [17 ]Early Psychosis: Interventions and Clinical-detection Laboratory, Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King’s Collect London, London, UK
                [18 ]OASIS Service, South London and Maudsley NHS Foundation Trust, London, UK
                [19 ]Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy
                [20 ]National Institute for Health Research, Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, UK
                [21 ]Bristol Medical School, University of Bristol, Bristol, UK
                [22 ]Department of Critical Care Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
                Author notes
                Correspondence to: L Hartling hartling@ 123456ualberta.ca (or @arche4evidence on Twitter)
                Author information
                https://orcid.org/0000-0001-8341-3991
                Article
                bmj-2022-070849.R1 gatm070849
                10.1136/bmj-2022-070849
                9361065
                35944924
                ea5a2597-60ea-4e20-a282-106f2743617e
                © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

                This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

                History
                : 30 May 2022
                Categories
                Research

                Medicine
                Medicine

                Comments

                Comment on this article